Design and study of piracetam-like nootropics, controversial members of the problematic class of cognition-enhancing drugs

Current Pharmaceutical Design

Volumn 8, Issue 2, 2002, Pages 125-138

  Gualtieri, Fulvio ^a   Manetti, Dina ^a   Romanelli, Maria Novella ^a   Ghelardini, Carla ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

1 [1 (2 TRIFLUOROMETHYL 4 PYRIMIDINYL) 4 PIPERIDINYLMETHYL] 2 PYRROLIDINONE; 5 ISOPROPOXY 1 [[3 (TRIFLUOROMETHYL)PHENYL]SULFONYL] 2 PYRROLIDINONE; 6 QUINOXALINECARBOXYLIC ACID PIPERIDIDE; ANIRACETAM; BIFEMELANE; CYCLANDELATE; ETIRACETAM; EXIFONE; FASORACETAM; HOPANTENIC ACID; IDEBENONE; INDELOXAZINE; LINOPIRDINE; MECLOFENOXATE; MEMANTINE; NAFTIDROFURYL; NEBRACETAM; NEBRACETAM FUMARATE; NEFIRACETAM; NICERGOLINE; NOOTROPIC AGENT; OXIRACETAM; PIDOTIMOD; PIRACETAM; PRAMIRACETAM; PROPENTOFYLLINE; ROLIPRAM; ROLZIRACETAM; STEROID; ULB L059; UNINDEXED DRUG; VINCAMINE;

AGING; ALZHEIMER DISEASE; ARTICLE; ATTENTION; BRAIN FUNCTION; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DRUG CLASSIFICATION; DRUG DESIGN; DRUG MECHANISM; DRUG RESEARCH; DRUG SAFETY; DRUG SCREENING; DRUG STRUCTURE; DRUG TOLERABILITY; HEAD INJURY; HUMAN; INFORMATION RETRIEVAL; LEARNING; MOUSE; NEUROBIOLOGY; NONHUMAN; PATHOLOGY; PREDICTION; PRIORITY JOURNAL; RAT; STROKE; STRUCTURE ACTIVITY RELATION;

ACETYLCHOLINE; ANIMALS; COGNITION DISORDERS; DRUG DESIGN; HUMANS; NOOTROPIC AGENTS; PIRACETAM; STRUCTURE-ACTIVITY RELATIONSHIP; TECHNOLOGY, PHARMACEUTICAL;

EID: 0036235070     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/1381612023396582     Document Type: Article

References (122)